bpc-157 for neuropathy inflammation autoimmune & The Gut-Brain Axis: A Practitioner's Definitive Review of the Evidence Autoimmune Conditions and Peptide Therapy

Description

Ask your provider where their peptides come from and whether the pharmacy holds current USP compliance

BPC-157 supports this interconnected system by: Strengthening tight junctions between intestinal epithelial cells, reducing intestinal permeability (leaky gut) Modulating the enteric nervous system to normalize motility and reduce visceral hypersensitivity Regulating mucosal immune responses to prevent inappropriate inflammation against dietary and microbial antigens Conditions Treated with Oral BPC-157 Beyond Symptom Relief: Addressing Root Causes Unlike proton pump inhibitors (PPIs) that suppress stomach acid or corticosteroids that broadly dampen immunity, BPC-157 works by restoring the underlying structural and functional integrity of the gastrointestinal tract